These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K. Scand J Rheumatol; 2007 May; 36(4):291-8. PubMed ID: 17763207 [Abstract] [Full Text] [Related]
3. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases. Salonen EM, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H. Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381 [Abstract] [Full Text] [Related]
4. Autoantibodies in patients with oral lupus erythematosus, lichen planus and leukoplakia. An aid in diagnosis. Schiødt M, Permin H, Wiik A, Manthorpe R. Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):59-63. PubMed ID: 6603096 [Abstract] [Full Text] [Related]
5. [Neurological manifestations of systemic lupus erythematosus. Study of 53 cases]. Migliaresi S, Di Iorio G, Picillo U, Tedeschi G, Santanelli P, Di Costanzo A, Della Cioppa G, Fasolino M, Diano A, Bonavita V. Ann Ital Med Int; 1989 Feb; 4(1):10-5. PubMed ID: 2518398 [Abstract] [Full Text] [Related]
6. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus]. Horák P, Hermanová Z, Faltýnek L, Pospísil Z, Scudla V. Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876 [Abstract] [Full Text] [Related]
7. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. Pradhan VD, Badakere SS, Bichile LS, Almeida AF. J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975 [Abstract] [Full Text] [Related]
8. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Ainiala H, Hietaharju A, Dastidar P, Loukkola J, Lehtimäki T, Peltola J, Korpela M, Heinonen T, Nikkari ST. Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328 [Abstract] [Full Text] [Related]
9. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease. Souza A, da Silva LM, Oliveira FR, Roselino AM, Louzada-Junior P. Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860 [Abstract] [Full Text] [Related]
10. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC. Arthritis Res Ther; 2006 Mar; 8(6):R162. PubMed ID: 17062137 [Abstract] [Full Text] [Related]
11. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus. Bardin N, Desplat-Jego S, Daniel L, Jourde Chiche N, Sanmarco M. Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456 [Abstract] [Full Text] [Related]
13. [Capacity to predict a recurrence of lupus erythematosus using double-stranded anti-DNA antibodies and Farr technique]. Massardo L, Martínez ME, Pérez R, Ramírez V, Foradori A, González A, Radrigán F, Gutiérrez F, Jacobelli S. Rev Med Chil; 1999 Apr; 127(4):411-20. PubMed ID: 10451606 [Abstract] [Full Text] [Related]
14. Anti-centromere antibodies in patients with systemic lupus erythematosus. Respaldiza N, Wichmann I, Ocaña C, Garcia-Hernandez FJ, Castillo MJ, Magariño MI, Magariño R, Torres A, Sanchez-Roman J, Nuñez-Roldan A. Scand J Rheumatol; 2006 Apr; 35(4):290-4. PubMed ID: 16882593 [Abstract] [Full Text] [Related]
15. Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE? Al Attia HM. Int J Dermatol; 2006 Apr; 45(4):366-9. PubMed ID: 16650159 [Abstract] [Full Text] [Related]
16. VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics. van Vollenhoven RF, Bieber MM, Powell MJ, Gupta PK, Bhat NM, Richards KL, Albano SA, Teng NN. J Rheumatol; 1999 Aug; 26(8):1727-33. PubMed ID: 10451069 [Abstract] [Full Text] [Related]
17. [Disseminated lupus erythematosus without antinuclear antibodies or other autoantibodies]. Duc J, Perroulaz G, Golaz J, Campiche M, Pécoud A. Schweiz Med Wochenschr; 1987 Feb 07; 117(6):205-8. PubMed ID: 3494306 [Abstract] [Full Text] [Related]
18. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Husebye ES, Sthoeger ZM, Dayan M, Zinger H, Elbirt D, Levite M, Mozes E. Ann Rheum Dis; 2005 Aug 07; 64(8):1210-3. PubMed ID: 15708887 [Abstract] [Full Text] [Related]
19. [Comparison of severity and native anti-DNA antibody levels in systemic lupus erythematosus. Serodiscordant lupus]. Manent-Ducreuzet C, Margulis J, Kahn MF. Rev Rhum Mal Osteoartic; 1981 Nov 07; 48(11):705-12. PubMed ID: 6975965 [Abstract] [Full Text] [Related]
20. Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus. Almogren A. Saudi Med J; 2010 Jan 07; 31(1):32-6. PubMed ID: 20062896 [Abstract] [Full Text] [Related] Page: [Next] [New Search]